Why It Matters

The stakes for this hearing are stark. The United States faces intensifying global competition for technological dominance, particularly with China’s systematic push toward self-sufficiency in semiconductors, quantum computing, and AI. American economic strength and national security are now inseparable from leadership in frontier technologies.

At stake:

  • Semiconductor supply chain resilience. The U.S. maintains a 56 percent global market share, but China is rapidly building domestic capacity projected to reach $100 billion by 2030.

  • Quantum computing leadership. With global markets projected to reach $97 billion by 2035, the U.S. must establish coherent national policy through initiatives like the Quantum LEAP Act.

  • AI innovation dominance. While the U.S. leads in private investment, the quality gap with international competitors is closing rapidly.

  • Critical supply chains. COVID-19 exposed vulnerabilities; reshoring faces structural barriers requiring coordinated federal incentives.

  • International standards authority. China is executing a deliberate strategy to dominate global tech governance.

    • Core issues being discussed:

    Bipartisan legislation reflects consensus priorities: strengthening IP protections through the RESTORE Patent Rights Act; accelerating patent review via the Leadership in CET Act; expanding R&D tax incentives through the American Innovation and R&D Competitiveness Act; revitalizing domestic medical manufacturing with the MMEDS Act; and securing semiconductor supply chains through the SEMI Investment Act.

    Broader Context

    Congress is intensifying focus on frontier technologies as part of a broader strategy to maintain U.S. economic and national security leadership. The November 18 hearing reflects years of legislative momentum around innovation policy.

    Key initiatives setting the stage:

    The bipartisan RESTORE Patent Rights Act seeks stronger injunction protections, while the Leadership in CET Act aims to fast-track patent reviews for AI and semiconductor technologies.

    The SEMI Investment Act expands tax incentives for domestic semiconductor production. The MMEDS Act uses similar incentives to revitalize pharmaceutical manufacturing.

    The American Innovation and R&D Competitiveness Act would allow companies to immediately expense R&D investments rather than amortize them over years.

    A June 2025 Joint Economic Committee hearing established consensus on domestic manufacturing reshoring, automation adoption, and regulatory reform needs. The November hearing represents the next step: translating priorities into concrete policy.

    The Agenda

    The Joint Economic Committee hearing will feature witnesses addressing frontier technologies and industrial policy, with participation from key members with established expertise:

    • Senator Marsha Blackburn (R-TN) has championed patents for critical technologies and quantum computing policy
    • Senator Tom Cotton (R-AR) focuses on patent protections for American innovators
    • Senator Mark Kelly (D-AZ) brings national security perspectives on technological innovation
    • Representative Ron Estes (R-KS-4) advocates for R&D tax incentives
    • Representative Sean Casten (D-IL-6) champions government financing for clean energy and advanced manufacturing
    • Representative Nicole Malliotakis (R-NY-11) introduced legislation to revitalize domestic medical manufacturing

    Additional participants include Senators Amy Klobuchar (D-MN), Maggie Hassan (D-NH), Eric Schmitt (R-MO), and Representatives Gwen Moore (D-WI-4), David Schweikert (R-AZ-1), and Don Beyer (D-VA-8).

    Between The Lines

    Committee Leadership and Legislative Priorities

    Senator Marsha Blackburn (R-TN) is driving the committee’s innovation agenda, championing the Leadership in CET Act, Quantum LEAP Act, and SEMI Investment Act.

    Senator Tom Cotton (R-AR) co-sponsors the RESTORE Patent Rights Act to strengthen patent protections. Representative Ron Estes (R-KS-4) reintroduced the American Innovation and R&D Competitiveness Act.

    Representative Sean Casten (D-IL-6) led efforts urging the Department of Energy to maintain its Loan Program Office for financing advanced manufacturing projects.

    Senators Blackburn and Mark Warner introduced the Promoting United States Leadership in Standards Act to counter Chinese influence in global technology standards.

    Competitive Landscape

    Corporate lobbying reveals intense focus on the hearing’s priorities. The Technology CEO Council has advocated throughout 2025 for semiconductor manufacturing leadership, AI competitiveness, and R&D tax incentives.

    Schneider Electric USA Inc. is lobbying on advanced manufacturing automation, CHIPS Act implementation, and workforce development. ArcelorMittal North America Holdings LLC focuses on manufacturing investment and trade enforcement.

    Corporate engagement demonstrates alignment around R&D tax incentives, domestic manufacturing capacity expansion, and strategic trade policy—issues directly addressed by the committee’s legislative agenda.

    The Bottom Line

    The Joint Economic Committee hearing reflects broad bipartisan consensus: American technological leadership requires concrete federal action through R&D tax incentives, patent protections, semiconductor supply chain reshoring, and quantum computing strategy.

    Committee members’ legislative priorities cluster around accelerating innovation through tax policy, strengthening IP protections, and securing critical manufacturing capacity. The lobbying landscape confirms high stakes, with major corporations actively engaging throughout 2025.

    The hearing presents an opportunity for stakeholders to demonstrate how specific policies translate into tangible economic outcomes rather than abstract competitiveness goals.

    For more detailed insights access Legis1. Request a demo today!

    Spot something wrong? Report an issue with this article